Summary
Gene therapy represents a frontier in medical science, offering the prospect of cure for previously incurable genetic disorders.
Central to this promise are adeno- associated virus (AAV) vectors, the vehicles for delivering therapeutic genes to patients’ cells. However, the commercial success and accessibility of gene therapies hinges on overcoming significant challenges in scalability and testing.
Download this short article to learn more about how WuXi Advanced Therapies is addressing these challenges.